Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15023)

• Formulation Name: Naproxen 220 mg tablet
• Company: 7-Eleven; Aidarex Pharmaceuticals; American Sales Company; Amerisource Bergen; Army & Air Force Exchange Service; Avera McKennan Hospital; CVS Pharmacy; Cardinal Health; DZA Brands; Dispensing Solution; Dolgencorp; H E B; Hy-Vee; Kmart Corporation; Kroger Company; L Perrigo Company; L. Perrigo Company; Lake Eire Medical & Surgical Supply DBA Quality Care Products; McKesson; Meijer; NuCare Pharmaceuticals; Perrigo New York; Preferred Pharamaceuticals; Proficient Rx; Publix Super Markets; Rite Aid; Rugby Laboratories; Safeway; Sam's West; Save-A-Lot Food Stores; Shopko; SuperValu; TYA Pharmaceuticals; Target Corporation; Topco Associates; Wakefern Food Corporation; Wal-Mart Stores; Walgreens Company

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Naproxen	(DMZ5RGV)	Bursitis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent